BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage develop…
Biotechnology
US, Palo Alto [HQ]
BBIO/Financial Reporting
Income Statements
Profit & Loss · 7 Statements · From 2023 to 2017Configuration
In Million USD. Margins, Growth Rates In %
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | - - | - - | 40.00 | 8.00 | 69.00 | 77.00 | 9.00 | |
|
EPS
|
-0.33 | -1.42 | -2.48 | -4.10 | -4.43 | -3.35 | -3.95 | |
| Diluted in mil. | -0.33 | -1.42 | -2.48 | -4.10 | -4.43 | -3.35 | -3.95 | |
|
Profit
|
- - | - - | 38.00 | 5.00 | 66.00 | 74.00 | 6.00 | |
| Gross Margin | - - | - - | 93.84 | 62.57 | 95.53 | 95.58 | 73.71 | |
| Pre Tax | -43.00 | -169.00 | -288.00 | -505.00 | -586.00 | -484.00 | -653.00 | |
| Profit Margin | - - | - - | -711.50 | -6,127.87 | -841.20 | -624.17 | -7,021.94 | |
| ETR | 30.77 | -9.89 | 9.75 | 4.27 | -9.01 | -1.92 | -10.95 | |
| Net | -30.00 | -130.00 | -260.00 | -483.00 | -639.00 | -493.00 | -643.00 | |
| Profit Margin | - - | - - | -642.10 | -5,866.47 | -917.00 | -636.16 | -6,913.92 | |
| EBITDA | -43.00 | -182.00 | -279.00 | -468.00 | -539.00 | -353.00 | -574.00 | |
| EBITDA Margin | - - | - - | -688.87 | -5,683.51 | -774.11 | -455.49 | -6,176.95 | |
| Operating Income | -43.00 | -183.00 | -266.00 | -474.00 | -579.00 | -471.00 | -607.00 | |
| Operating Margin | - - | - - | -656.41 | -5,751.99 | -831.58 | -607.71 | -6,528.75 | |
| Interest Income | - - | 2.00 | 8.00 | 4.00 | 1.00 | 7.00 | 18.00 | |
| Loss | -43.00 | -183.00 | -306.00 | -482.00 | -646.00 | -546.00 | -608.00 | |
| Cost of Revenue | - - | - - | -2.00 | -3.00 | -3.00 | -3.00 | -2.00 | |
|
Operating Expenses
|
-43.00 | -183.00 | -304.00 | -482.00 | -646.00 | -546.00 | -606.00 | |
| R&D | -30.00 | -140.00 | -209.00 | -337.00 | -454.00 | -402.00 | -455.00 | |
| G&A | -13.00 | -43.00 | -94.00 | -145.00 | - - | - - | - - | |
| SG&A | -13.00 | -43.00 | -94.00 | -145.00 | -192.00 | -143.00 | -150.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | - - | - - | - - | -3.00 | -5.00 | -6.00 | -6.00 | |
| Interest Expenses | - - | -2.00 | -8.00 | -36.00 | -46.00 | -80.00 | -81.00 | |
| Other Expenses | - - | -14.00 | -22.00 | -31.00 | -6.00 | -12.00 | -9.00 | |
|
WA Shares Outstanding
|
92.00 | 92.00 | 105.00 | 117.00 | 144.00 | 147.00 | 162.00 | |
| Diluted | 92.00 | 92.00 | 105.00 | 117.00 | 144.00 | 147.00 | 162.00 |